Tigermed discloses CSRC probe into two controlling shareholders over shareholding disclosure practices

Bulletin Express

May 12

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) announced that the China Securities Regulatory Commission (CSRC) has opened an investigation into two of its directors and controlling shareholders, Mr. Ye Xiaoping and Ms. Cao Xiaochun, for alleged violations of information-disclosure requirements related to changes in their shareholdings.

The company received the CSRC’s case-filing notice on 12 May 2026. The investigation is being conducted under the Securities Law of the People’s Republic of China and the Administrative Penalty Law. Tigermed stated that both individuals will fully cooperate with regulators and comply with all disclosure obligations.

According to the board, the Group’s business operations remain normal, and management does not expect the probe to disrupt day-to-day activities. The company will issue further announcements as developments occur.

Tigermed advises shareholders and potential investors to exercise caution when trading its shares. The board is chaired by Mr. Ye Xiaoping; the board currently comprises four executive directors and three independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1129069966"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129069966\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129069966?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129069966","market":"us","top_or_hot":-1,"title":"Tigermed discloses CSRC probe into two controlling shareholders over shareholding disclosure practices","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) announced that the China Securities Regulatory Commission (CSRC) has opened an investigation into two of its directors and controlling shareholders, Mr. Ye Xiaoping and Ms. Cao Xiaochun, for alleged violations of information-disclosure requirements related to changes in their shareholdings.</p>\n<p>The company received the CSRC’s case-filing notice on 12 May 2026. The investigation is being conducted under the Securities Law of the People’s Republic of China and the Administrative Penalty Law. Tigermed stated that both individuals will fully cooperate with regulators and comply with all disclosure obligations.</p>\n<p>According to the board, the Group’s business operations remain normal, and management does not expect the probe to disrupt day-to-day activities. The company will issue further announcements as developments occur.</p>\n<p>Tigermed advises shareholders and potential investors to exercise caution when trading its shares. The board is chaired by Mr. Ye Xiaoping; the board currently comprises four executive directors and three independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed discloses CSRC probe into two controlling shareholders over shareholding disclosure practices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed discloses CSRC probe into two controlling shareholders over shareholding disclosure practices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-12 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) announced that the China Securities Regulatory Commission (CSRC) has opened an investigation into two of its directors and controlling shareholders, Mr. Ye Xiaoping and Ms. Cao Xiaochun, for alleged violations of information-disclosure requirements related to changes in their shareholdings.</p>\n<p>The company received the CSRC’s case-filing notice on 12 May 2026. The investigation is being conducted under the Securities Law of the People’s Republic of China and the Administrative Penalty Law. Tigermed stated that both individuals will fully cooperate with regulators and comply with all disclosure obligations.</p>\n<p>According to the board, the Group’s business operations remain normal, and management does not expect the probe to disrupt day-to-day activities. The company will issue further announcements as developments occur.</p>\n<p>Tigermed advises shareholders and potential investors to exercise caution when trading its shares. The board is chaired by Mr. Ye Xiaoping; the board currently comprises four executive directors and three independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1129069966","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129069966","pubTimestamp":1778590976,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) announced that the China Securities Regulatory Commission (CSRC) has opened an investigation into two of its directors and controlling shareholders,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药披露证监会就持股披露行为对两名控股股东立案调查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) announced that the China Securities Regulatory Commission (CSRC) has opened an investigation into two of its directors and controlling shareholders, Mr. Ye Xiaoping and Ms. Cao Xiaochun, for alleged violations of information-disclosure requirements related to changes in their shareholdings.\nThe company received the CSRC’s case-filing notice on 12 May 2026. The investigation is being conducted under the Securities Law of the People’s Republic of China and the Administrative Penalty Law. Tigermed stated that both individuals will fully cooperate with regulators and comply with all disclosure obligations.\nAccording to the board, the Group’s business operations remain normal, and management does not expect the probe to disrupt day-to-day activities. The company will issue further announcements as developments occur.\nTigermed advises shareholders and potential investors to exercise caution when trading its shares. The board is chaired by Mr. Ye Xiaoping; the board currently comprises four executive directors and three independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}